Agilent Technologies, Inc. $A Shares Sold by TD Asset Management Inc

TD Asset Management Inc trimmed its holdings in Agilent Technologies, Inc. (NYSE:A) by 4.7% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,053,785 shares of the medical research company’s stock after selling 51,509 shares during the quarter. TD Asset Management Inc’s holdings in Agilent Technologies were worth $143,389,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the business. Massachusetts Financial Services Co. MA raised its position in shares of Agilent Technologies by 13.8% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after buying an additional 1,713,216 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Agilent Technologies by 4.8% in the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock valued at $1,203,990,000 after buying an additional 433,342 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Agilent Technologies by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after buying an additional 25,139 shares during the last quarter. Generation Investment Management LLP raised its position in shares of Agilent Technologies by 10.1% in the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock valued at $816,043,000 after buying an additional 582,093 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at about $549,158,000.

Agilent Technologies Trading Up 0.6%

Shares of A opened at $138.23 on Friday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The firm has a 50-day moving average price of $117.89 and a 200 day moving average price of $128.30. The firm has a market capitalization of $39.04 billion, a P/E ratio of 27.76, a P/E/G ratio of 2.45 and a beta of 1.26.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.84 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same quarter in the prior year, the firm posted $1.31 earnings per share. Agilent Technologies’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.99 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is 20.48%.

Analysts Set New Price Targets

A number of brokerages have recently commented on A. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and reduced their target price for the company from $150.00 to $145.00 in a research report on Thursday, May 28th. Robert W. Baird increased their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, May 28th. Barclays upped their price objective on shares of Agilent Technologies from $140.00 to $145.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Finally, Royal Bank Of Canada initiated coverage on shares of Agilent Technologies in a report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and an average target price of $161.71.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.